Overview
Smart money at a glance
Filings to Sep 30, 2026Net selling: insiders sold $259K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$259K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 5 added, 3 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $21.62
- 52-wk high
- $36.98
- High
- $21.91
- 52-wk low
- $19.55
- Low
- $21.03
- Prev close
- $19.59
- Mkt cap
- $9.73B
- Volume
- 16.03M
- Fwd P/E
- 12.6x
- Beta
- 1.63
- P/S
- 1.6x
- P/B
- 18.5x
- Profit margin
- -2.7%
- Op margin
- -4.7%
- ROE
- -21.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about DKNG filings
Are insiders buying or selling DraftKings Inc (DKNG) stock?
Net selling: insiders sold $259K and bought $0 of DKNG stock on the open market in the 90 days to Sep 30, 2026, according to SEC Form 4 filings. $259K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Moore, Jocelyn (Director), who sold $259K. The latest filing was on Aug 20, 2026.
Which members of Congress have traded DKNG recently?
None. No member of Congress disclosed a DKNG trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this DKNG smart-money data?
This summary uses filings available on Sep 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- QR

Qube Research
$62.9M
bought
Sells/Trims (2)
- VG

Viking Global
$658.9M
sold
- P7

Point72
$54.5M
sold
What insiders are doing
How top traders are positioned
Earnings
Earnings came in $0.16 a share below what analysts expected.
Earnings per share
$0.08 expected
Reports Nov 5, 2026, in 36 days
Estimates as of Sep 29, 2026
EPS expected
-$0.30 to -$0.04
Revenue expected
28 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.14B | $1.99B | $1.65B | $1.44B |
| Cost of what it sold | $784.1M | $1.07B | $949.4M | $891.8M |
| Gross profit | $359.9M | $914.7M | $696.7M | $551.5M |
| What it spent | ||||
| Research and development | $114.7M | $133.6M | $123.2M | $127.6M |
| Sales and admin | $156.8M | $186.7M | $165.9M | $169.4M |
| Other operating costs | $360.4M | $442.6M | $401.7M | $322.5M |
| Total operating expenses | $631.8M | $762.9M | $690.8M | $619.6M |
| What was left | ||||
| Operating profit | -$271.9M | $151.8M | $5.8M | -$68.2M |
| Interest on debt | $19.6M | $5.4M | $5.7M | $7.4M |
| Profit before tax | -$268.9M | $146.6M | $27.4M | -$71.9M |
| Tax | -$12.1M | $10.1M | $6.4M | -$4.2M |
| Net profit | -$256.8M | $136.4M | $21.1M | -$67.6M |
| EBITDA | -$159.1M | $220.6M | $93.4M | $8.5M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace